Intra-Aortic Balloon Pump (IABP): Mechanism

 Intra-Aortic Balloon Pump (IABP):

● Mechanism of Action:

Inflation during diastole → Increases aortic diastolic pressure → ↑ Coronary perfusion.

Deflation before systole → Decreases afterload → ↓ LV workload → ↑ Stroke volume and cardiac output.

Intra-Aortic Balloon Pump (IABP): Principles, Indications, and Clinical Use

The intra-aortic balloon pump (IABP) is a temporary mechanical circulatory support device used to augment coronary perfusion and reduce left ventricular afterload. It works on the principle of counterpulsation, synchronized with the cardiac cycle.

Basic Principle (Counterpulsation)

The IABP consists of a balloon mounted on a catheter, positioned in the descending thoracic aorta just distal to the left subclavian artery.

• Balloon inflates during diastole

• Balloon deflates just before systole

This timing improves myocardial oxygen supply and decreases myocardial oxygen demand.

Hemodynamic Effects

1. Diastolic inflation

• Increases aortic diastolic pressure

• Augments coronary artery perfusion

• Improves cerebral and systemic perfusion

2. Systolic deflation

• Reduces aortic end-diastolic pressure

• Decreases left ventricular afterload

• Reduces myocardial oxygen consumption

• Increases stroke volume and cardiac output (modest increase)

Overall effects

• Improved cardiac output (10–20%)

• Reduced LV wall stress

• Improved coronary blood flow

Indications

1. Cardiogenic shock (especially post-MI)

2. Acute MI with mechanical complications (acute MR, VSD)

3. Refractory unstable angina

4. Acute decompensated heart failure with low output

5. Support during high-risk PCI

6. Bridge to definitive therapy (CABG, LVAD, transplant)

7. Post-cardiac surgery low output state

Contraindications

Absolute

• Severe aortic regurgitation

• Aortic dissection

Relative

• Severe peripheral arterial disease

• Abdominal or thoracic aortic aneurysm

• Uncontrolled sepsis

• Severe coagulopathy

Insertion Technique

• Usually inserted percutaneously via femoral artery

• Balloon size selected based on patient height

• Correct position: tip 2–3 cm below left subclavian artery, above renal arteries

• Placement confirmed by fluoroscopy or chest X-ray

Timing and Triggering

Triggering modes

• ECG triggering (most common)

• Arterial pressure waveform

Correct timing

• Inflation at dicrotic notch (aortic valve closure)

• Deflation just before systolic upstroke

Incorrect timing leads to reduced benefit or hemodynamic worsening.

Monitoring Parameters

• Augmented diastolic pressure

• Assisted vs unassisted systolic pressure

• Mean arterial pressure

• Urine output

• Lactate levels

• Limb perfusion and pulses

Complications

Vascular

• Limb ischemia

• Femoral artery injury

• Hematoma

• Pseudoaneurysm

Non-vascular

• Thrombocytopenia

• Hemolysis

• Infection

• Balloon rupture

• Stroke (rare)

Weaning from IABP

Methods

• Reduce assist ratio (1:1 → 1:2 → 1:3)

• Gradual reduction in balloon volume

Prerequisites for weaning

• Hemodynamic stability

• Adequate cardiac output

• Minimal inotropic support

Evidence and Current Role

Large trials (e.g., IABP-SHOCK II) showed no mortality benefit in routine use of IABP for cardiogenic shock complicating MI. As a result, routine use has declined, but IABP remains valuable in selected patients due to ease of use, rapid deployment, and favorable safety profile compared with other mechanical support devices.

Key Takeaway

IABP is a diastolic augmentation device that improves coronary perfusion and reduces afterload. While not a replacement for advanced mechanical circulatory support, it remains a useful adjunct in carefully selected clinical scenarios.